P

Porton Pharma Solutions Ltd
SZSE:300363

Watchlist Manager
Porton Pharma Solutions Ltd
SZSE:300363
Watchlist
Price: 16.51 CNY -0.84%
Market Cap: 9B CNY
Have any thoughts about
Porton Pharma Solutions Ltd?
Write Note

Porton Pharma Solutions Ltd
Investor Relations

Porton Pharma Solutions Ltd., rooted in the vibrant landscape of China's pharmaceutical sector, has strategically navigated its way to becoming a pivotal player in the global Contract Development and Manufacturing Organization (CDMO) industry. Founded in 2005, the company harnesses the intricate synergy between chemistry and biology to drive its core operations. Porton specializes in providing a comprehensive suite of services ranging from early drug development to commercial-scale manufacturing. The company's business model thrives on forming collaborative partnerships with global pharmaceutical and biotechnology firms, offering customized solutions tailored to specific drug production needs. By acting as an extension of its clients' research and development teams, Porton effectively reduces the time and investment required for its clients to bring new drugs to market, catalyzing its own revenue through long-standing service agreements.

The essence of Porton’s value proposition lies in its robust technological capabilities and commitment to compliance with international quality standards, which ensures client trust and repeat business. Porton's facilities are outfitted with cutting-edge technologies that support complex chemical synthesis and advanced bioprocessing, allowing them to expertly handle high-potency and complex molecules. Additionally, the company leverages its strategic geographic advantage in China to offer competitive pricing while maintaining quality excellence, a crucial factor in contracting agreements. Through continuous investments in research and development, and a commitment to operational efficiency, Porton Pharma Solutions Ltd. not only accelerates its clients' drug development timelines but also enhances its own profitability, positioning itself as a leader in the evolving CDMO landscape.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Nianfeng Ju
Chairman & GM
No Bio Available
Mr. Hui Chen
Deputy GM & CFO
No Bio Available
Mr. Yinchun Bai
Senior Deputy GM & COO
No Bio Available
Ms. Pi Wei
Deputy General Manager & Secretary
No Bio Available
Mr. Yuanming Huang
Deputy General Manager
No Bio Available

Contacts

Address
CHONGQING
Chongqing
R & D Center of New Drug Outsourcing Service Base, Porton Pharma Solutions Ltd., Fangzheng Avenue, Water and Soil Park, Beibei District
Contacts
+862365936900
www.porton.cn